Views & Analysis Just how much does the NHS spend on medicines? Confidential discounts and the PPRS pricing system are making it more difficult to arrive at an accurate figure.
Views & Analysis The budget impact of new medicines What could be the impact of proposed new ‘budget impact threshold’ for drugs?
Views & Analysis The PPRS medicines pricing scheme: is it working for both si... The PPRS has now reached the half-way stage - a look at the stats so far.
Views & Analysis Flexible models for better access Which initiatives are the most likely to bring life-changing therapies to patients?
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
